Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Volin, L
[Clear All Filters]
2016
Volin L
,
Niittyvuopio R
,
Heiskanen J
,
Lindström V
,
Nihtinen A
,
Sahlstedt L
,
Ruutu T
.
Diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome of the liver: problems of interpretation.
Bone Marrow Transplant. 2016.
PubMed
Google Scholar
Koenecke C
,
Heim D
,
van Biezen A
,
Heuser M
,
Aljurf M
,
Kyrcz-Krzemien S
,
Volin L
,
de Souza CA
,
Gedde-Dahl T
,
Sengeloev H
, et al.
Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party.
Bone Marrow Transplant. 2016.
PubMed
Google Scholar
2015
Passweg JR
,
Labopin M
,
Cornelissen J
,
Volin L
,
Socié G
,
Huynh A
,
Tabrizi R
,
Wu D
,
Craddock C
,
Schaap N
, et al.
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT.
Bone Marrow Transplant. 2015.
PubMed
Google Scholar
Iacobelli S
,
de Wreede LC
,
Schönland S
,
Björkstrand B
,
Hegenbart U
,
Gruber A
,
Greinix H
,
Volin L
,
Narni F
,
Carella AM
, et al.
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial.
Bone Marrow Transplant. 2015.
PubMed
Google Scholar